Skip to main content

Client News

Galimedix appoints Dr. Luciana Summo as Vice President, R&D Operations

25th October 2023

Abivax announces Closing of its Initial Public Offering on the Nasdaq Global Market

24th October 2023

Carbios Places Sustainability at the Heart of its Governance with New Appointment to its Executive Committee

23rd October 2023

Abivax announces trading resumption of its ordinary shares on Euronext Paris

20th October 2023

Abivax announces the pricing of its Initial Public Offering on the Nasdaq Global Market

20th October 2023

Abivax announces temporary trading halt of its ordinary shares on Euronext Paris

20th October 2023

Abivax announces the filing of an amended registration statement, including an estimated initial public offering price range

19th October 2023

Mainz Biomed Presents Groundbreaking Results of ColoFuture Study

18th October 2023

Secarna Pharmaceuticals to present two posters showcasing the innovation potential of the LNAplus platform at the 19th Annual Meeting of the Oligonucleotide Therapeutic Society

17th October 2023

Abivax announces the start of the roadshow for its proposed global offering and proposed Nasdaq listing

16th October 2023